Reversibility of the anticoagulant effect of high doses of the direct thrombin inhibitor, dabigatran, by recombinant factor VIIa or activated prothrombin complex concentrate. 13th Congress of the European Hematology Association, Copenhagen, Denmark - Van Ryn, J; Ruehl, D; Priepke, H (2008)
June